Published in J Neurol Neurosurg Psychiatry on October 01, 1996
Olfactory dysfunction in Parkinson disease. Nat Rev Neurol (2012) 1.73
Olfaction and taste processing in autism. Biol Psychiatry (2007) 1.29
Olfactory deficits, cognition and negative symptoms in early onset psychosis. Schizophr Res (2005) 1.05
Profound olfactory dysfunction in myasthenia gravis. PLoS One (2012) 0.87
Prenatal alcohol exposure selectively enhances young adult perceived pleasantness of alcohol odors. Physiol Behav (2015) 0.81
Cognitive, sensory, and psychosocial characteristics in patients with Bardet-Biedl syndrome. Am J Med Genet A (2013) 0.81
Cranial nerve I: olfaction. Psychiatry (Edgmont) (2009) 0.80
Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome. Sci Rep (2011) 0.77
Olfaction in People with Down Syndrome: A Comprehensive Assessment across Four Decades of Age. PLoS One (2016) 0.75
Emerging Putative Associations between Non-Coding RNAs and Protein-Coding Genes in Neuropathic Pain: Added Value from Reusing Microarray Data. Front Neurol (2016) 0.75
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav (1984) 6.50
Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology (1988) 2.72
Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull (1987) 1.79
Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys (1989) 1.63
Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 1.50
Down's syndrome and Alzheimer's disease: a review. Psychol Med (1986) 1.31
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol (1995) 1.22
Alzheimer's disease and Down's syndrome. Histopathology (1988) 1.18
Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration (1995) 1.15
Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg (1988) 1.12
Alzheimer's disease and Down's syndrome. Ann N Y Acad Sci (1982) 1.01
Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology (1993) 0.99
Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology (1991) 0.96
Olfactory identification deficits in Down's syndrome and idiopathic mental retardation. Neuropsychologia (1993) 0.85
Smell and taste function in the visually impaired. Percept Psychophys (1993) 0.84
Olfactory deficits and Down's syndrome. Biol Psychiatry (1988) 0.82
Olfactory deficits in Down subjects: a link with Alzheimer disease. Percept Mot Skills (1994) 0.80
Alzheimer's disease in Down's syndrome. A review. J Am Geriatr Soc (1986) 0.80
Will the study of Down syndrome solve the riddle of Alzheimer disease? J Pediatr (1986) 0.80
Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav (1984) 6.50
Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med (1974) 4.10
University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope (1984) 3.80
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology (2003) 3.62
Sexual health of teenagers in England and Wales: analysis of national data. BMJ (1999) 3.54
Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA (1999) 3.22
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20
Smell identification ability: changes with age. Science (1984) 2.87
New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep CDR Suppl (1998) 2.83
A neuronal morphologic type unique to humans and great apes. Proc Natl Acad Sci U S A (1999) 2.81
Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat Genet (1995) 2.66
Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science (1980) 2.45
Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg (1991) 2.34
The biomedical effects of laser application. Lasers Surg Med (1985) 2.34
Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol (1998) 2.29
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry (2011) 2.28
The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol (2000) 2.08
The pathology of Legionnaires' disease. Fourteen fatal cases from the 1977 outbreak in Vermont. Arch Pathol Lab Med (1978) 2.06
Rising mortality from motoneuron disease in the USA, 1962-84. Lancet (1989) 2.05
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02
Bacterial vaginosis: a public health review. BJOG (2001) 1.95
Dose-related effects of cigarette smoking on olfactory function. JAMA (1990) 1.94
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol (1996) 1.87
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry (2011) 1.85
Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull (1987) 1.79
The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol (2000) 1.72
Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry (1997) 1.71
Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav (1978) 1.69
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol (1995) 1.69
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68
Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys (1989) 1.63
Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science (1982) 1.63
Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry (1999) 1.62
Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology (1996) 1.60
Two decades of increasing mortality from Parkinson's disease among the US elderly. Arch Neurol (1990) 1.56
Sex differences in odor identification ability: a cross-cultural analysis. Neuropsychologia (1985) 1.55
Investigation of a fatality from nonoccupational aluminum phosphide exposure: measurement of aluminum in tissue and body fluids as a marker of exposure. J Lab Clin Med (1993) 1.53
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry (1996) 1.52
Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology (1999) 1.50
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50
A review of olfactory dysfunctions in man. Am J Otolaryngol (1979) 1.49
Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol (1988) 1.49
Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol (1998) 1.45
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem (1995) 1.41
Progressive dementia and gait disorder in a 78 year old woman. J Neurol Neurosurg Psychiatry (2000) 1.39
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry (1998) 1.39
Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol (1992) 1.38
Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry (2012) 1.35
Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol (1992) 1.33
Surveillance of sexually transmitted infections in primary care. Sex Transm Infect (2003) 1.32
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology (2005) 1.30
Increasing gonorrhoea reports--not only in London. Lancet (2000) 1.29
Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol (1994) 1.26
Kallmann syndrome: MR evaluation of olfactory system. AJNR Am J Neuroradiol (1993) 1.24
Postmortem studies in schizophrenia. Schizophr Bull (1998) 1.23
Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience (2003) 1.22
Odor-guided behavior in mammals. Experientia (1986) 1.22
Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol (1995) 1.22
Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry (2000) 1.21
Endocrine, cardiovascular, and psychological correlated of olfactory sensitivity changes during the human menstrual cycle. J Comp Physiol Psychol (1981) 1.19
Congenital syphilis in the United Kingdom. Sex Transm Infect (2006) 1.17
Taste and smell perception in depression. Biol Psychiatry (1987) 1.16
Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol (1994) 1.16
Provision of diagnostic services for genital chlamydial infection in genitourinary medicine clinics: England and Wales 1996. Genitourin Med (1997) 1.16
Adult onset Hallervorden-Spatz disease with neurofibrillary pathology. A discrete clinicopathological entity. Brain (1987) 1.14
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res (1992) 1.14
Syphilis surveillance and epidemiology in the United Kingdom. Euro Surveill (2004) 1.13
Influence of epilepsy and temporal lobe resection on olfactory function. Epilepsia (1995) 1.12
Olfactory sensitivity, nasal resistance, and autonomic function in patients with multiple chemical sensitivities. Arch Otolaryngol Head Neck Surg (1988) 1.12
A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol (1998) 1.11
Olfactory function in Parkinson's disease subtypes. Neurology (1994) 1.10
The validity of the family history method for identifying Alzheimer disease. Arch Neurol (1997) 1.09
Changes in the intensity and pleasantness of human vaginal odors during the menstrual cycle. Science (1975) 1.09
Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience (2002) 1.08
Relationship of aluminum to Alzheimer's disease. Environ Health Perspect (1985) 1.07
A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Eur Neurol (1997) 1.07
Multiple microabscesses in the central nervous system: a clinicopathologic study. J Neuropathol Exp Neurol (1989) 1.06
Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry (1998) 1.05
Ultrasound in Crohn's disease of the small bowel. Eur J Radiol (2000) 1.04
Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol (1996) 1.04
An immunocytochemical comparison of cytoskeletal proteins in aluminum-induced and Alzheimer-type neurofibrillary tangles. Acta Neuropathol (1986) 1.04
Posttraumatic smell loss: relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Acad Radiol (1999) 1.03
Olfactory dysfunction in three neurodegenerative diseases. Geriatrics (1991) 1.02
Spiral CT colonography in inflammatory bowel disease. Eur J Radiol (2000) 1.01
MR evaluation of patients with congenital hyposmia or anosmia. AJR Am J Roentgenol (1996) 1.01
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch Neurol (2000) 1.01
Posttraumatic olfactory dysfunction: MR and clinical evaluation. AJNR Am J Neuroradiol (1996) 1.00
MRI and PET studies of manganese-intoxicated monkeys. Neurology (1995) 1.00
Ongoing outbreak of Shigella flexneri serotype 3a in men who have sex with men in England and Wales, data from 2009-2011. Euro Surveill (2012) 1.00
Cytology of human caudomedial cingulate, retrosplenial, and caudal parahippocampal cortices. J Comp Neurol (2001) 1.00
Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex. J Neuropathol Exp Neurol (2001) 1.00
Surveillance of HTLV infection in England and Wales: 1986-1992. Commun Dis Rep CDR Rev (1994) 1.00
Sexually transmitted diseases among teenagers in England and Wales. Commun Dis Rep CDR Rev (1997) 0.99
Familial myoclonic dementia masquerading as Creutzfeldt-Jakob disease. Ann Neurol (1986) 0.98
Communication of gender from human axillary odors: relationship to perceived intensity and hedonicity. Behav Biol (1978) 0.97
Diencephalic amnesia: a reappraisal. J Neurol Neurosurg Psychiatry (1976) 0.97